1. Marsh, K 1998  Malaria Disaster in Africa  Lancet  352: 924-25

2. Trape JF, Pison G, Preziosi MP et al  1998  Impact of chloroquine resistance of malaria mortality  C R Acad Sci Paris Serie III 321: 689-97

3. Schapira A, Beales PF, Halloran ME  1993  Malaria: Living with Drug Resistance  Parasitology Today  9 (5) 168-174

4. Phillips Howard PA  1998  Confronting the challenge of antimalarial drug resistance in Africa, Managing the introduction of new antimalarial drugs to Africa: Theory and Practice  WHO report

5. N J White, F Nosten, S Looareesuwan, W M Watkins, K Marsh, R W Snow, G Kokwaro, J Ouma, T T Hien, M E Molyneux, T E Taylor, C I Newbold, T K Ruebush II, M Danis, B M Greenwood, R M Anderson, P Olliaro, 1999 Averting a malaria disaster  Lancet 353: 1965-67

6. Govere J, la Grange K, Durrheim DN, Sharp B, Freese J, Mabuza A, and Mngomezulu N 1999  Sulfadoxine / pyrimethamine (SP) effectiveness against P. falciparum malaria in Mpumalanga Province, South Africa Trans R Soc Trop Med Hyg (in press).

7. Bac DJ, Cox GA & Isaacson M, 1985. In vivo and in vitro chloroquine-resistant malaria in South Africa. S Afr Med J, 67: 937 - 938.

8. Visagie NJ & Sieling WL, 1985. Chloroquine-resistant Plasmodium falciparum malaria South Africa. S Afr Med J, 68: 600 - 601.

9. Kruger P, Durrheim DN & Hansford CF. Increasing chloroquine resistance: the Mpumalanga Lowveld story, 1990-1995. S Afr Med J 1996; 73: 280 - 281.

10. Freese JA, Robinson A, et al  1997  Sensitivity to chloroquine and sulfadoxine / pyrimethamine of Plasmodium falciparum in KwaZulu Natal  (Unpublished report)

11. Ronn AM, Msangeni HA, Mhina J, Wernsdorfer WH, Bygbjerg IC   1996  High level of resistance of Plasmodium falciparum to sulphadoxine – pyrimethamine in children in Tanzania  Trans R Soc Trop Med Hyg  90: 179-181

12. South African Department of Health notification data

13. Price RN, Nosten F, Luxemborger C, ter Kuile FO, Paiphun L, Chongsuphajaisiddhi T, White NJ  1996  Effects of artemisinin derivatives on malaria transmissibility  Lancet 347: 1654-58

14. White NJ  1997  Assessment of the pharmacodynamic properties of anti-malarial drugs in vivo  Antimicrob Agents Chemother 41: 1413-22

15. Wilkins J, Barnes KI, Valentine N, Folb PI Cost effectiveness of alternative antimalarials  (in draft)

16. White NJ  1998  Preventing antimalarial drug resistance through combinations  Drug Resistance Updates 1:3-9

17. Price RN, Nosten F, Luxemburger C, et al. Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria. Trans R Soc Trop Med Hyg 1997; 91: 574-77

18. Van Vugt M, Brockman A, Gemperli B, et al. Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria. Antimicrob Agents Chemother 1998; 42: 135-39

19. F Nosten, M van Vugt, R price, C Luxemborger, KL Thway, A Brockman, R McGready, F ter Kuile, S Looareesuwan, NJ White (2000).    Effects of artesunate - mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in Western Thailand: a prospective study.  Lancet; 356: 297-302

20 Handunnetti SM, Gunewardena DM, Pathirana PPSL, Ekanayake K, Weerasinghe S, Mendis KN. Features of recrudescent chloroquine-resistant Plasmodium falciparum infections confer a survival advantage on parasites and have implications for disease control. Trans R Soc Trop Med Hyg 1996; 90: 563-67 

Back to Introduction